{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:19:33Z","timestamp":1772947173208,"version":"3.50.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2024ZD047"],"award-info":[{"award-number":["2024ZD047"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.clinre.2025.102653","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T23:39:57Z","timestamp":1753745997000},"page":"102653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics profiling and molecular pathways in esophageal adenocarcinoma"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2692-7099","authenticated-orcid":false,"given":"Qi","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0001","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2478\/jtim-2023-0126","article-title":"PRP improves the outcomes of autologous skin graft transplantation on the esophagus by promoting angiogenesis and inhibiting fibrosis and inflammation","volume":"12","author":"Xu","year":"2024","journal-title":"J Transl Int Med"},{"issue":"5","key":"10.1016\/j.clinre.2025.102653_bib0002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1515\/jtim-2024-0017","article-title":"Gastroesophageal reflux disease influences blood pressure components, lipid profile and cardiovascular diseases: evidence from a mendelian randomization study","volume":"12","author":"Wu","year":"2024","journal-title":"J Transl Int Med"},{"issue":"8","key":"10.1016\/j.clinre.2025.102653_bib0003","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s10620-018-5068-6","article-title":"Thrift AP: barrett's esophagus and esophageal adenocarcinoma: how common are they really?","volume":"63","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.clinre.2025.102653_bib0004","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1158\/1055-9965.EPI-22-0096","article-title":"eQTL set-based association analysis identifies novel susceptibility loci for Barrett esophagus and esophageal adenocarcinoma","volume":"31","author":"Wang","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7793","key":"10.1016\/j.clinre.2025.102653_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.clinre.2025.102653_bib0006","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.cell.2022.04.017","article-title":"Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders","volume":"185","author":"Porubsky","year":"2022","journal-title":"Cell"},{"issue":"42","key":"10.1016\/j.clinre.2025.102653_bib0007","doi-asserted-by":"crossref","first-page":"15450","DOI":"10.1021\/acs.analchem.3c02029","article-title":"Spatial transcriptomics: emerging technologies in tissue gene expression profiling","volume":"95","author":"Robles-Remacho","year":"2023","journal-title":"Anal Chem"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0008","article-title":"Prebiotic proanthocyanidins inhibit bile reflux-induced esophageal adenocarcinoma through reshaping the gut microbiome and esophageal metabolome","volume":"9","author":"Weh","year":"2024","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.clinre.2025.102653_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11864-021-00884-7","article-title":"HER2-Directed therapy in advanced gastric and gastroesophageal adenocarcinoma: triumphs and troubles","volume":"22","author":"Grieb","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"10418","key":"10.1016\/j.clinre.2025.102653_bib0010","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.clinre.2025.102653_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103663","article-title":"Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials","volume":"9","author":"Lordick","year":"2024","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.clinre.2025.102653_bib0012","article-title":"SPOTlight on GLOW","volume":"4","author":"Derks","year":"2023","journal-title":"Cell Rep Med"},{"issue":"10389","key":"10.1016\/j.clinre.2025.102653_bib0013","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0014","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0015","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2478\/jtim-2023-0112","article-title":"Long-term outcomes of esophageal and gastric cancer patients with cardiovascular and metabolic diseases: a two-center propensity score-matched cohort study","volume":"11","author":"Zhou","year":"2023","journal-title":"J Transl Int Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0016","first-page":"21","article-title":"Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data","volume":"3","author":"Chen","year":"2023","journal-title":"J Natl Cancer Cent"},{"issue":"9","key":"10.1016\/j.clinre.2025.102653_bib0017","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.7326\/M24-0377","article-title":"The ethics of cancer screening based on race and ethnicity","volume":"177","author":"M\u00fclder","year":"2024","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.clinre.2025.102653_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051408","article-title":"Correlations between molecular alterations, histopathological characteristics, and poor prognosis in esophageal adenocarcinoma","volume":"15","author":"Orsini","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinre.2025.102653_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116121","article-title":"An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53","volume":"265","author":"Huang","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"11","key":"10.1016\/j.clinre.2025.102653_bib0020","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41588-022-01216-7","article-title":"TP53-dependent genomic instability","volume":"54","author":"Danovi","year":"2022","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0021","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10388-021-00835-z","article-title":"Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas","volume":"18","author":"Booka","year":"2021","journal-title":"JCGA. Esophagus"},{"key":"10.1016\/j.clinre.2025.102653_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.743133","article-title":"Glycolysis changes the microenvironment and therapeutic response under the driver of gene mutation in esophageal adenocarcinoma","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11033-023-09097-7","article-title":"TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress","volume":"51","author":"Zhu","year":"2024","journal-title":"Mol Biol Rep"},{"issue":"61","key":"10.1016\/j.clinre.2025.102653_bib0024","doi-asserted-by":"crossref","first-page":"104123","DOI":"10.18632\/oncotarget.22021","article-title":"Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma","volume":"8","author":"Ten Kate","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/nyas.13134","article-title":"Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma","volume":"1381","author":"Kalatskaya","year":"2016","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13148-022-01287-7","article-title":"Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus","volume":"14","author":"Pinto","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"9","key":"10.1016\/j.clinre.2025.102653_bib0027","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/ng.3343","article-title":"Paired exome analysis of Barrett's esophagus and adenocarcinoma","volume":"47","author":"Stachler","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99524-1","article-title":"CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer","volume":"11","author":"Gutiontov","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0029","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/01945998221089186","article-title":"A novel external auditory canal squamous cell carcinoma cell line sensitive to CDK4\/6 inhibition","volume":"168","author":"Garc\u00eda-Mar\u00edn","year":"2023","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/0008-5472.CAN-22-0391","article-title":"Combination therapies with CDK4\/6 inhibitors to treat KRAS-mutant pancreatic cancer","volume":"83","author":"Goodwin","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2025.102653_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2020.108360","article-title":"Role and potential clinical utility of ARID1A in gastrointestinal malignancy","volume":"787","author":"Wang","year":"2021","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0032","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/onc.2012.586","article-title":"Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus","volume":"33","author":"Streppel","year":"2014","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0033","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3892\/ol.2023.13840","article-title":"Quaas A: morphological, clinical and molecular characteristics in ARID1a\u2011deficient microsatellite\u2011stable oesophageal adenocarcinoma","volume":"25","author":"Rehkaemper","year":"2023","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clinre.2025.102653_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2019.09.004","article-title":"Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma","volume":"94","author":"Lowenthal","year":"2019","journal-title":"Hum Pathol"},{"issue":"22","key":"10.1016\/j.clinre.2025.102653_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225377","article-title":"ARID1A Deficiency regulates anti-tumor immune response in esophageal adenocarcinoma","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.clinre.2025.102653_bib0036","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-14-0849","article-title":"ARID1A Deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors","volume":"5","author":"Shen","year":"2015","journal-title":"Cancer Discov"},{"issue":"44","key":"10.1016\/j.clinre.2025.102653_bib0037","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1038\/sj.onc.1206751","article-title":"Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells","volume":"22","author":"Duda","year":"2003","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0038","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/PAS.0000000000000356","article-title":"Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival","volume":"39","author":"Singhi","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0039","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gut.2005.076430","article-title":"Impaired transforming growth factor beta signalling in Barrett's carcinogenesis due to frequent SMAD4 inactivation","volume":"55","author":"Onwuegbusi","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166867","article-title":"SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma","volume":"1870","author":"Foley","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.clinre.2025.102653_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1372272","article-title":"Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations","volume":"15","author":"Groen-van Schooten","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.clinre.2025.102653_bib0042","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/modpathol.2011.52","article-title":"Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation","volume":"24","author":"Langer","year":"2011","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0043","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000080928","article-title":"ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus","volume":"70","author":"Nishigaki","year":"2004","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0044","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/1078-0432.CCR-11-2272","article-title":"Association of HER2\/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas","volume":"18","author":"Yoon","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12885-018-5242-4","article-title":"HER2\/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma","volume":"19","author":"Plum","year":"2019","journal-title":"BMC Cancer"},{"issue":"24","key":"10.1016\/j.clinre.2025.102653_bib0046","doi-asserted-by":"crossref","first-page":"6248","DOI":"10.1158\/1078-0432.CCR-18-1128","article-title":"Analysis of circulating tumor DNA and clinical correlates in patients with esophageal, gastroesophageal junction, and gastric adenocarcinoma","volume":"24","author":"Kato","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0047","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1440-1827.2010.02545.x","article-title":"Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus","volume":"60","author":"Ooi","year":"2010","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0048","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.surg.2009.04.008","article-title":"ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas","volume":"146","author":"Arrington","year":"2009","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0049","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcad001","article-title":"Oncogenic ERRB2 signals through the AP-1 transcription factor to control mesenchymal-like properties of oesophageal adenocarcinoma","volume":"5","author":"Ogden","year":"2023","journal-title":"NAR Cancer"},{"key":"10.1016\/j.clinre.2025.102653_bib0050","article-title":"Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma","author":"Yates","year":"2025","journal-title":"bioRxiv"},{"issue":"17","key":"10.1016\/j.clinre.2025.102653_bib0051","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-11-3893","article-title":"Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis","volume":"72","author":"Dulak","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0052","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.gastro.2017.03.004","article-title":"Esophageal adenocarcinoma cells and xenograft tumors exposed to erb-b2 receptor tyrosine kinase 2 and 3 inhibitors activate transforming growth factor beta signaling, which induces epithelial to mesenchymal transition","volume":"153","author":"Ebbing","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2025.102653_bib0053","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/ncomms6224","article-title":"Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis","volume":"5","author":"Nones","year":"2014","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.clinre.2025.102653_bib0054","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1158\/1078-0432.CCR-08-2494","article-title":"Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma","volume":"15","author":"Paulson","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.clinre.2025.102653_bib0055","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1055-9965.EPI-05-0837","article-title":"Rabinovitch PS: chromosomal instability in Barrett's esophagus is related to telomere shortening","volume":"15","author":"Finley","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0056","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1158\/1940-6207.CAPR-08-0121","article-title":"Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression","volume":"1","author":"Li","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"issue":"11","key":"10.1016\/j.clinre.2025.102653_bib0057","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00042737-200211000-00004","article-title":"Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization","volume":"14","author":"Croft","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0058","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tips.2024.01.009","article-title":"Targeting chromosomal instability and aneuploidy in cancer","volume":"45","author":"Bhatia","year":"2024","journal-title":"Trends Pharmacol Sci"},{"issue":"1\u20132","key":"10.1016\/j.clinre.2025.102653_bib0059","first-page":"133","article-title":"Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression","volume":"547","author":"Doak","year":"2004","journal-title":"Mutat Res"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10577-023-09730-y","article-title":"Chromosomal instability and inflammation: a catch-22 for cancer cells","volume":"31","author":"van den Brink","year":"2023","journal-title":"Chromosome Res"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0061","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/gcc.22504","article-title":"Extreme chromosome 17 copy number instability is a prognostic factor in patients with gastroesophageal adenocarcinoma: a retrospective cohort study","volume":"57","author":"Birkness","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"issue":"13","key":"10.1016\/j.clinre.2025.102653_bib0062","first-page":"4819","article-title":"Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia","volume":"9","author":"Miller","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0063","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/gcc.22143","article-title":"Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis","volume":"53","author":"Frankel","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.clinre.2025.102653_bib0064","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41591-020-1033-y","article-title":"Genomic copy number predicts esophageal cancer years before transformation","volume":"26","author":"Killcoyne","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40246-015-0044-0","article-title":"Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma","volume":"9","author":"Wang","year":"2015","journal-title":"Hum Genomics"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0066","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/modpathol.2008.150","article-title":"DNA copy number alterations correlate with survival of esophageal adenocarcinoma patients","volume":"22","author":"Pasello","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clinre.2025.102653_bib0067","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4939-7734-5_21","article-title":"Epigenetics: DNA methylation analysis in esophageal adenocarcinoma","volume":"1756","author":"Islam","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102653_bib0068","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/epi.6.12.18199","article-title":"DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses","volume":"6","author":"Kaz","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.clinre.2025.102653_bib0069","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13148-017-0409-4","article-title":"Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma","volume":"9","author":"Luebeck","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"8","key":"10.1016\/j.clinre.2025.102653_bib0070","first-page":"2912","article-title":"Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma","volume":"9","author":"Brock","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.clinre.2025.102653_bib0071","first-page":"3410","article-title":"Epigenetic patterns in the progression of esophageal adenocarcinoma","volume":"61","author":"Eads","year":"2001","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001356","article-title":"Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis","volume":"7","author":"Alvarez","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.clinre.2025.102653_bib0073","article-title":"Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas","volume":"7","author":"Peng","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0074","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13059-023-03035-3","article-title":"Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation","volume":"24","author":"Zheng","year":"2023","journal-title":"Genome Biol"},{"issue":"14","key":"10.1016\/j.clinre.2025.102653_bib0075","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1158\/0008-5472.CAN-08-0700","article-title":"Baylin SB: defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells","volume":"68","author":"McGarvey","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.clinre.2025.102653_bib0076","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021795118","article-title":"Depletion of H3K36me2 recapitulates epigenomic and phenotypic changes induced by the H3.3K36M oncohistone mutation","volume":"118","author":"Rajagopalan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10.1016\/j.clinre.2025.102653_bib0077","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164084","article-title":"Histone modifying enzymes as targets for therapeutic intervention in oesophageal adenocarcinoma","volume":"13","author":"Pickering","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clinre.2025.102653_bib0078","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57189","article-title":"Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma","volume":"9","author":"Rogerson","year":"2020","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.clinre.2025.102653_bib0079","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s10620-011-1711-1","article-title":"Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer","volume":"56","author":"Li","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.clinre.2025.102653_bib0080","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2013.01.019","article-title":"Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma","volume":"144","author":"Wu","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0081","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gutjnl-2013-305266","article-title":"Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells","volume":"63","author":"Yang","year":"2014","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.clinre.2025.102653_bib0082","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.18632\/oncotarget.1927","article-title":"Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis","volume":"5","author":"Lee","year":"2014","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.clinre.2025.102653_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022009","article-title":"Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas","volume":"6","author":"Peng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2025.102653_bib0084","first-page":"12","article-title":"Sharrocks AD: eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways","author":"Ahmed","year":"2023","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1053\/j.gastro.2019.01.263","article-title":"Systems biology analyses show hyperactivation of transforming growth factor-\u03b2 and JNK signaling pathways in esophageal cancer","volume":"156","author":"Blum","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0086","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2013.08.017","article-title":"The esophagitis to adenocarcinoma sequence; the role of inflammation","volume":"345","author":"Kavanagh","year":"2014","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/j.clinre.2025.102653_bib0087","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/gut.2007.121244","article-title":"COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma","volume":"56","author":"Song","year":"2007","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0088","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejca.2014.11.014","article-title":"Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinoma","volume":"51","author":"Abdel-Latif","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.clinre.2025.102653_bib0089","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1158\/1078-0432.CCR-20-4707","article-title":"Next-generation sequencing of 487 esophageal adenocarcinomas reveals independently prognostic genomic driver alterations and pathways","volume":"27","author":"Sihag","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.clinre.2025.102653_bib0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jcmgh.2018.01.012","article-title":"siRNA library screening identifies a druggable immune-signature driving esophageal adenocarcinoma cell growth","volume":"5","author":"Duggan","year":"2018","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.clinre.2025.102653_bib0091","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/ijc.32384","article-title":"Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction","volume":"145","author":"Bornschein","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinre.2025.102653_bib0092","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2018.09.017","article-title":"Single-cell RNA sequencing reveals diverse intratumoral heterogeneities and gene signatures of two types of esophageal cancers","volume":"438","author":"Wu","year":"2018","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.clinre.2025.102653_bib0093","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gutjnl-2019-320368","article-title":"Dissecting transcriptional heterogeneity in primary gastric adenocarcinoma by single cell RNA sequencing","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2025.102653_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103459","article-title":"Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma","volume":"69","author":"Chen","year":"2021","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100764","article-title":"Multi-omic analysis of esophageal adenocarcinoma uncovers candidate therapeutic targets and cancer-selective posttranscriptional regulation","volume":"23","author":"O'Neill","year":"2024","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"10.1016\/j.clinre.2025.102653_bib0096","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1074\/mcp.M116.065078","article-title":"Quantitative shotgun proteomics unveils candidate novel esophageal adenocarcinoma (EAC)-specific proteins","volume":"16","author":"O'Neill","year":"2017","journal-title":"Mol Cell Proteomics"},{"issue":"24","key":"10.1016\/j.clinre.2025.102653_bib0097","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/cncr.28963","article-title":"Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma","volume":"120","author":"Zaidi","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0098","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.athoracsur.2007.03.088","article-title":"Diagnosis of esophageal adenocarcinoma by serum proteomic pattern","volume":"84","author":"Hammoud","year":"2007","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.clinre.2025.102653_bib0099","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/bjc.2012.15","article-title":"Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer","volume":"106","author":"Kelly","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinre.2025.102653_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2022.104684","article-title":"Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS","volume":"266","author":"Guo","year":"2022","journal-title":"J Proteomics"},{"issue":"24","key":"10.1016\/j.clinre.2025.102653_bib0101","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1158\/1078-0432.CCR-08-0679","article-title":"Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response","volume":"14","author":"Langer","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.clinre.2025.102653_bib0102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023985","article-title":"Discovery of new molecular subtypes in oesophageal adenocarcinoma","volume":"6","author":"Berg","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0103","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41467-023-36462-8","article-title":"Integrative proteomic characterization of adenocarcinoma of esophagogastric junction","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.clinre.2025.102653_bib0104","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.cgh.2015.05.023","article-title":"Identification of serum markers of esophageal adenocarcinoma by global and targeted metabolic profiling","volume":"13","author":"Sanchez-Espiridion","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030181","article-title":"Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0106","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jtcvs.2010.08.025","article-title":"Metabolomics study of esophageal adenocarcinoma","volume":"141","author":"Zhang","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"17","key":"10.1016\/j.clinre.2025.102653_bib0107","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.ejca.2013.07.004","article-title":"Metabolomic profiling of oesophago-gastric cancer: a systematic review","volume":"49","author":"Abbassi-Ghadi","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinre.2025.102653_bib0108","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5469597","article-title":"Metabolic perturbation and potential markers in patients with esophageal cancer","author":"Zhu","year":"2017","journal-title":"Gastroenterol Res Pract"},{"issue":"27","key":"10.1016\/j.clinre.2025.102653_bib0109","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.jchromb.2009.07.039","article-title":"Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography\/mass spectrometry","volume":"877","author":"Wu","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"10.1016\/j.clinre.2025.102653_bib0110","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1038\/s41467-023-38891-x","article-title":"Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy","volume":"14","author":"MN","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.clinre.2025.102653_bib0111","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/path.5828","article-title":"Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients","volume":"256","author":"Buck","year":"2022","journal-title":"J Pathol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740125001305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:22:20Z","timestamp":1772896940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740125001305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":111,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2210740125001305"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102653","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics profiling and molecular pathways in esophageal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2025.102653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102653"}}